Virios Therapeutics Announces Publication of International Patent for IMC-2 Covering Antiviral Treatment of Long-COVID

- New patent would extend coverage and expand potential value of Virios’ antiviral pipeline globally –

- Active Long-COVID characterized by immune dysfunction leading to recurrent herpesviruses reactivation -